Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Perloff

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 25, 2000
Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end pointA Decensi, R Torrisi, S Bruno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B studyM Perloff, L Norton, A H Korzun, et al.
Journal of the National Cancer Institute|November 5, 1999
Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancerU Veronesi, G De Palo, E Marubini, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 25, 2000
Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end pointA Decensi, R Torrisi, S Bruno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B studyM Perloff, L Norton, A H Korzun, et al.
Journal of the National Cancer Institute|November 5, 1999
Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancerU Veronesi, G De Palo, E Marubini, et al.
Pageof 7